Gellai M - Search Results

1

Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin AT1 receptor antagonist.

Aiyar N, Baker E, Vickery-Clark L, Ohlstein EH, Gellai M, Fredrickson TA, Brooks DP, Weinstock J, Weidley EF, Edwards RM. Aiyar N, et al. Among authors: gellai m. Eur J Pharmacol. 1995 Sep 5;283(1-3):63-72. doi: 10.1016/0014-2999(95)00287-u. Eur J Pharmacol. 1995. PMID: 7498322

2

Inhibition of vasopressin-sensitive cAMP accumulation by alpha 2-adrenoceptor agonists in collecting tubules is species dependent.

Edwards RM, Stack EJ, Gellai M, Brooks DP. Edwards RM, et al. Among authors: gellai m. Pharmacology. 1992;44(1):26-32. doi: 10.1159/000138870. Pharmacology. 1992. PMID: 1348126

3

The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.

Ohlstein EH, Gellai M, Brooks DP, Vickery L, Jugus J, Sulpizio A, Ruffolo RR Jr, Weinstock J, Edwards RM. Ohlstein EH, et al. Among authors: gellai m. J Pharmacol Exp Ther. 1992 Aug;262(2):595-601. J Pharmacol Exp Ther. 1992. PMID: 1501114

4

Antihypertensive activity of the non-peptide angiotensin II receptor antagonist, SK&F 108566, in rats and dogs.

Brooks DP, Fredrickson TA, Weinstock J, Ruffolo RR Jr, Edwards RM, Gellai M. Brooks DP, et al. Among authors: gellai m. Naunyn Schmiedebergs Arch Pharmacol. 1992 Jun;345(6):673-8. doi: 10.1007/BF00164582. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1635591

5

The water diuretic effect of the alpha-2 adrenoceptor agonist, AGN 190851, is species-dependent.

Brooks DP, Edwards RM, Depalma PD, Fredrickson TA, Hieble JP, Gellai M. Brooks DP, et al. Among authors: gellai m. J Pharmacol Exp Ther. 1991 Dec;259(3):1277-82. J Pharmacol Exp Ther. 1991. PMID: 1684820

6

Inhibition of vasopressin-stimulated cyclic AMP accumulation by alpha-2 adrenoceptor agonists in isolated papillary collecting ducts.

Edwards RM, Gellai M. Edwards RM, et al. Among authors: gellai m. J Pharmacol Exp Ther. 1988 Feb;244(2):526-30. J Pharmacol Exp Ther. 1988. PMID: 2894453

7

Antihypertensive effects of the endothelin receptor antagonist BQ-123 in conscious spontaneously hypertensive rats.

Ohlstein EH, Douglas SA, Ezekiel M, Gellai M. Ohlstein EH, et al. Among authors: gellai m. J Cardiovasc Pharmacol. 1993;22 Suppl 8:S321-4. doi: 10.1097/00005344-199322008-00084. J Cardiovasc Pharmacol. 1993. PMID: 7509976

8

Nonpeptide endothelin receptor antagonists. V: Prevention and reversal of acute renal failure in the rat by SB 209670.

Gellai M, Jugus M, Fletcher T, Nambi P, Ohlstein EH, Elliott JD, Brooks DP. Gellai M, et al. J Pharmacol Exp Ther. 1995 Oct;275(1):200-6. J Pharmacol Exp Ther. 1995. PMID: 7562550

9

SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist.

Ohlstein EH, Nambi P, Douglas SA, Edwards RM, Gellai M, Lago A, Leber JD, Cousins RD, Gao A, Frazee JS, et al. Ohlstein EH, et al. Among authors: gellai m. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8052-6. doi: 10.1073/pnas.91.17.8052. Proc Natl Acad Sci U S A. 1994. PMID: 8058755 Free PMC article.

10

Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083.

Douglas SA, Nambi P, Gellai M, Luengo JI, Xiang JN, Brooks DP, Ruffolo RR Jr, Elliott JD, Ohlstein EH. Douglas SA, et al. Among authors: gellai m. J Cardiovasc Pharmacol. 1998;31 Suppl 1:S273-6. doi: 10.1097/00005344-199800001-00077. J Cardiovasc Pharmacol. 1998. PMID: 9595458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters